Literature DB >> 14644625

Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes.

James F Dillman1, Kriston L McGary, John J Schlager.   

Abstract

The vesicant sulfur mustard is an alkylating agent that has the capacity to cross-link biological molecules. We are interested in identifying specific proteins that are altered upon sulfur mustard exposure. Keratins are particularly important for the structural integrity of skin, and several genetically inherited blistering diseases have been linked to mutations in keratin 5 and keratin 14. We examined whether sulfur mustard exposure alters keratin biochemistry in cultured human epidermal keratinocytes. Western blotting with specific monoclonal antibodies revealed the formation of stable high-molecular-weight "aggregates" containing keratin 14 and/or keratin 5. These aggregates begin to form within 15 min after sulfur mustard exposure. These aggregates display a complex gel electrophoresis pattern between approximately 100 and approximately 200 kDa. Purification and analysis of these aggregates by one- and two-dimensional gel electrophoresis and mass spectrometry confirmed the presence of keratin 14 and keratin 5 and indicate that at least some of the aggregates are composed of keratin 14-keratin 14, keratin 14-keratin 5, or keratin 5-keratin 5 dimers. These studies demonstrate that sulfur mustard induces keratin aggregation in keratinocytes and support further investigation into the role of keratin aggregation in sulfur mustard-induced vesication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644625     DOI: 10.1016/j.taap.2003.08.003

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

2.  Inflammatory effects of inhaled sulfur mustard in rat lung.

Authors:  Rama Malaviya; Vasanthi R Sunil; Jessica Cervelli; Dana R Anderson; Wesley W Holmes; Michele L Conti; Ronald E Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-07-24       Impact factor: 4.219

3.  Regulation of Hsp27 and Hsp70 expression in human and mouse skin construct models by caveolae following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.

Authors:  Adrienne T Black; Patrick J Hayden; Robert P Casillas; Diane E Heck; Donald R Gerecke; Patrick J Sinko; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2011-03-30       Impact factor: 4.219

4.  Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.

Authors:  Adrienne T Black; Patrick J Hayden; Robert P Casillas; Diane E Heck; Donald R Gerecke; Patrick J Sinko; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-16       Impact factor: 4.219

5.  Highly stable peptide adducts from hard keratins as biomarkers to verify local sulfur mustard exposure of hair by high-resolution mass spectrometry.

Authors:  Wolfgang Schmeißer; Markus Siegert; Horst Thiermann; Theo Rein; Harald John
Journal:  Arch Toxicol       Date:  2022-05-16       Impact factor: 6.168

Review 6.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

7.  Treatment of keratin intermediate filaments with sulfur mustard analogs.

Authors:  John F Hess; Paul G FitzGerald
Journal:  Biochem Biophys Res Commun       Date:  2007-05-29       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.